Samson Oluwapelumi Kosemani

Mr. Samson Oluwapelumi Kosemani

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SASamuel A. Akinseinde
Samuel A. Akinseinde
SKSamson Oluwapelumi Kosemani
Samson Oluwapelumi Kosemani
EOEmmanuel Osuolale
Emmanuel Osuolale
NCNina Cesare
Nina Cesare
SPSamantha Pellicane
Samantha Pellicane
ENElaine O. Nsoesie
Elaine O. Nsoesie
This study measures associations between COVID-19 deaths and sociodemographic factors (wealth, insurance coverage, urban residence, age, state population) for states in Nigeria across two waves of the COVID-19 pandemic: February 27th 2020 to October 24th 2020 and October 25th 2020 to July 25th 2021. Data sources include 2018 Nigeria Demographic and Health Survey and Nigeria Centre for Disease Control (NCDC) COVID-19 daily reports. It uses negative binomial models to model deaths, and stratifies results by respondent gender. It finds that overall mortality rates were concentrated within three states: Lagos, Edo and Federal Capital Territory (FCT) Abuja. Urban residence and insurance coverage are positively associated with differences in deaths for the full sample. The former, however, is significant only during the early stages of the pandemic. Associative differences in gender-stratified models suggest that wealth was a stronger protective factor for men and insurance a stronger protective factor for women. Associative strength between sociodemographic measures and deaths varies by gender and pandemic wave, suggesting that the pandemic impacted men and women in unique ways, and that the effectiveness of interventions should be evaluated for specific waves or periods.

Verified
Journal Article
Open access
PDF file
AAAdedoyin Omobolanle Adefisan-Adeoye
Adedoyin Omobolanle Adefisan-Adeoye
SKSamson Oluwapelumi Kosemani
Samson Oluwapelumi Kosemani
OAOlayinka Adebayo
Olayinka Adebayo
TATemitope D. Adeoye
Temitope D. Adeoye
JUJeremiah Unuofin
Jeremiah Unuofin
OAOluwatosin Adekunle Adaramoye
Oluwatosin Adekunle Adaramoye
The genus Calliandra (Leguminosae: Mimosoideae) encompasses over 200 species, many of which hold significant ethnobotanical value. However, a critical and comprehensive review consolidating their phytochemical and pharmacological knowledge is currently lacking. This article aims to provide a detailed and analytical overview of the traditional uses, phytochemistry, and pharmacological properties of the most studied Calliandra species, identifying trends, gaps, and future research priorities. A systematic literature search was conducted using Google Scholar, Scopus, Web of Science, and PubMed from 1986 to 2025. The review focuses on Calliandra portoricensis, Calliandra haematocephala, and Calliandra surinamensis due to the relative abundance of scientific literature concerning their medicinal applications. These species produce a diverse array of secondary metabolites, including distinctive galloylated flavonoids, phenolic acids, and triterpenes. Extracts and isolated compounds demonstrate a wide range of pharmacological activities, such as antioxidant, antimicrobial, anti-inflammatory, antidiabetic, and anticancer effects, providing a scientific basis for their traditional uses. The genus Calliandra represents a promising source of bioactive compounds. However, future research must focus on compound isolation, mechanistic studies, rigorous toxicological profiling, and clinical trials to fully realize its therapeutic potential.